Evidence map›Paper›PMID 32275927›Full record

ArticleNeuropharmacology2020

Neurotensin induces hypothermia by activating both neuronal neurotensin receptor 1 and astrocytic neurotensin receptor 2 in the median preoptic nucleus.

Iustin V Tabarean

Open access · greenAbstract read
In one paragraph

Article in Neuropharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Iustin V TabareanScintillon Institute, 6868 Nancy Ridge Drive, San Diego, 92121, CA, USA. Electronic address: tabarean@scintillon.org.
Scintillon Institute · US

Funding

Peptidergic modulation of thermoregulation and energy expenditureR01NS094800 · NINDS · SCRIPPS RESEARCH INSTITUTE, THE · PI TABAREAN, IUSTIN VIRGIL · 2015 to 2019
$2.2M
NINDS NIH HHS R01 NS094800
6 · The paper itself

Abstract

Neurotensin (NTS) is a neuropeptide acting as a neuromodulator in the brain and is a very potent hypothermic agent. However, the cellular mechanisms of actions are not fully understood. Here we report that NTS increases the firing rate of preoptic GABAergic neurons by activating both neurotensin receptor 1 (NTSR1) and neurotensin receptor 2 (NTSR2), expressed by neurons and astrocytes, respectively. Downstream of NTSR1 the neuropeptide activated an inward current, calcium release from intracellular stores and, postsynaptically, increased frequency and amplitude of inhibitory synaptic events. NTSR2 activation in astrocytes resulted in increased excitatory input in preoptic GABAergic neurons, an effect which was dependent upon the activation of P2X4 receptors. We also found that neuromedin N acted as a selective agonist at the NTSR1. Surprisingly, activation of both NTSR1 and NTSR2 in the median preoptic nucleus was required for activating a full hypothermic response.

Indexed as

NeurotensinAnimalsAstrocytesExcitatory Postsynaptic Potentialsgamma-Aminobutyric AcidHypothermiaMaleMiceMice, Inbred C57BLNeuronsPatch-Clamp TechniquesPreoptic AreaPurinergic P2X Receptor AgonistsReceptors, NeurotensinReceptors, Purinergic P2X4gamma-Aminobutyric AcidNeurotensinneurotensin type 1 receptorNtsr2 protein, mousePurinergic P2X Receptor AgonistsReceptors, NeurotensinReceptors, Purinergic P2X4HypothermiaMedian preoptic nucleusNeuromedin NNeurotensinNTSR1NTSR2

Identifiers

PMID32275927
PMCPMC7274271
OpenAlexW3015961892

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.